Haemacure to Present at the BioFinance 2008 Conference to be held at the Toronto Marriott Eaton Centre, May 6... ( HAE...)

Haemacure to Present at the BioFinance 2008 Conference to be held at the Toronto Marriott Eaton Centre, May 6 - 8, 2008

Date:5/1/2008

HAE:TSX

MONTREAL, May 1 /PRNewswire-FirstCall/ - Haemacure Corporation (TSX : HAE), a Montreal-based specialty bio-therapeutics company developing high-value human plasma-derived protein products for commercialization, announced today that Joseph Galli, Chairman and Chief Executive Officer, will present at BioFinance 2008 on Thursday, May 8th at 11:00am ET, in the Trinity Room at The Toronto Marriott Eaton Centre, Toronto, Ontario.

BioFinance 2008 is the Canadian Life Science industry's leading investor conference. The meeting brings together key industry players to consider investment opportunities and issues affecting companies in biotechnology, medical devices, diagnostics and research tools. Participants include senior life science executives, institutional and venture capital investors, industry analysts, corporate finance executives and experts from the scientific and medical communities in Canada, the United States, Europe and Asia.

About Haemacure

Haemacure Corporation is a specialty biotherapeutics company developing high-value human plasma-derived protein products for commercialization. Haemacure's research and development effort is driven by its proprietary plasma protein extraction technology to develop next-generation products, including surgical hemostats. Haemacure's lead product candidate, Hemaseel(R)HMN, is a fibrin sealant planned to enter pivotal Phase II/Phase III clinical trials during the first quarter of 2009. Haemacure's second product candidate is thrombin, a component of its fibrin sealant, now in preclinical stage. Follow-on development will focus on surgical hemostats, wound healing, adhesion prevention, regenerative medecine, drug delivery and combination with biomaterials. Haemacure has discovered eleven additional specialty proteins and enzymes in one if its two plasma fractions and seeks to advance these proteins and enzymes through partnerships with pharmaceutical and b
'/>"/>

SOURCE HAEMACURE CORPORATION
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine news :

1. Haemacure Discloses Positive Results of a preclinical study of its fibrin sealant in adhesion prevention and opens a new opportunity in a market with a significant unmet medical need
2. Haemacure Reports on its annual general and special meeting of shareholders
3. Media Invitation - Annual General and Special Meeting of Shareholders of Haemacure
4. Haemacure Announces Details of its Annual General and Special Meeting of Shareholders
5. Haemacure announces webcast of presentation at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conferencec
6. Haemacure Adopts Strategy for "First-Patient-In" Fibrin Sealant Pivotal Clinical Trials
7. Haemacure Reports Third Quarter 2007 Results
8. Paloma Pharmaceuticals Presents at the Association for Research in Vision and Ophthalmology Meeting
9. MedCath Corporation to Present at the Deutsche Bank Securities 33rd Annual Health Care Conference
10. Hospira to Present at the Bank of America 2008 Health Care Conference on May 14
11. EAU Technologies to Present at AeA Micro Cap Conference

Post Your Comments:

(Date:11/9/2009)...y, study finds, , , MONDAY, Nov. 9 (Hea...ug Plavix (clopidogrel) works about the same in wo...s has found. , "After this study, I can say we ...th this very important drug," said Dr. Jeffrey S. ...ew York University Langone Medical Center in New Y...

(Date:11/9/2009)...ditions are age-related, researchers say , ...urgery doesn,t appear to speed the progression of ...to a new study that challenges the belief that tre..., "Because both conditions are strongly age-rel...," wrote Li Ming Dong, of Stony Brook University S...

(Date:11/9/2009)... sexual function, study says, , , MON...ble to restore sexual function to rabbits with dam...ab and implanting it, a new study reports. , Th...s say the technique could one day be used to treat... able to show the tissue was able to integrate and...

(Date:11/9/2009)...s are often blamed for the increasing rates of chi...wever finds that 80% of people think that parents ... (PRWEB) November 9, 2009 -- If you th...d Australia’s obesity epidemic, think again....rs. A recent survey commissioned for Fitness.com....

(Date:11/9/2009)...ights positive influence of sports participation o... IL (Vocus) November 9, 2009 -- As people age frac...esearch has highlighted the importance of exercise...ues. However, a new study published in the Novembe...inary Approach reveals that there may be signific...

Breaking Medicine News(10 mins):Health News:No Gender Gap Found for Clot-Busting Drug 2 Health News:No Gender Gap Found for Clot-Busting Drug 3 Health News:Cataract Surgery Doesn't Worsen Macular Degeneration: Study 2 Health News:Scientists Grow New Penile Tissue in the Lab 2 Health News:Scientists Grow New Penile Tissue in the Lab 3 Health News:Fitness.com.au Poll Finds 80% Blame Parents For Our Overweight Kids 2 Health News:High Impact Sports Participation May Improve Bone Mineral Density in Mature Athletes 2

[0] No Gender Gap Found for Clot-Busting Drug [0] Cataract Surgery Doesn't Worsen Macular Degeneration: Study [0] Scientists Grow New Penile Tissue in the Lab [1] Fitness.com.au Poll Finds 80% Blame Parents For Our Overweight Kids [1] High Impact Sports Participation May Improve Bone Mineral Density in Mature Athletes

... Gay and lesbian civil partnerships (gay marriage)... benefits. Researchers said that such marriage lea...ariety of ways. // Civil partnerships for gay coup...the Journal of Epidemiology and Community Health s...

... Sudden Infant Death is thought to be spurred by t...ists from Bristol, England, have been able to asce...y of Bristol researchers have found certain sets o...ers.' The research team, led by Professor Julia...

... The state government is facing accusation from th...f health services in the state. // Reports are... a relapse within a month of being discharged from...alls, during the previous year. Apparently the gov...

... A new study published in the March 15, 2006 issue...n Cancer Society, says that the risk of a //new ca...ral breast cancer increases to a fair degree in wo...ith hereditary (non-BRCA) breast cancer greatly in...

... It has been proposed by the Jharkhand government ...mdev to exploit the potential of Ayurveda.// The y...y for manufacture and marketing of Ayurvedic medic... Ramdev next week when he arrives here for a yoga ...

... South East Asia has been long considered a wonder...bars, hotel lobbies or restaurants without any inh... the government is seriously thinking about imposi...nt offices, airports and other public venues like ...

Other Medicine News:Health News:Smoking Ban To Be Soon Implemented In South East Asian Bars 2

Betterment Of Health In Case Of Gay And Lesbian Civil Partnerships Causes of Sudden Infant Death Researched Opposition: Government turned a deaf ear to warnings about dwindling health care services Hereditary Non-BRCA Breast Cancer Can Trigger New Cancers Yoga Guru Ramdev Invited to Tap Ayurveda Potential by Jharkhand Govt Smoking Ban To Be Soon Implemented In South East Asian Bars

(Date:11/9/2009)..., VIRGINIA BEACH, Va., Nov. 9 Lif...ny, announces the launch of Vertigraft Cervical Bi..., Preservon® is a new, proprietary glycero...t bio-implants to be stored in a fully hydrated st...ed to freeze or freeze-dry bio-implants, doing awa...

(Date:11/9/2009)..., MIAMI, Nov. 9 ISTA Ph...ced additional results from the Company,s Bepreve(...% Phase 3 clinical studies. These results were pr...ing of the American College of Allergy, Asthma &am...n a poster presentation titled, "Treatment of Ocul...

(Date:11/9/2009)..., WALTHAM, Mass., Nov. 9 Decision...d advisory firms for pharmaceutical and healthcare...th factor receptor 2 (HER2) targeting therapies --...mithKline/Nippon Kayaku,s Tykerb/Tyverb -- were th...tment. Continued uptake of Herceptin and Tykerb/Ty...

[0] LifeNet Health Announces First Bio-Implant with New Preservation Technology [0] ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI)[0] Sales of HER2-Targeting Agents for Breast Cancer, Including Herceptin and Tykerb/Tyverb, Will Grow by 3.3 Percent Annually from 2008 to 2018

...or Medical Use Approval and Insurance Coverage Var...OCHESTER, N.Y. - April 30, 2007-- Most U.S. adults...nd procedures that can,impact people,s quality of ... fertilization, drugs to treat erectile,dysfunctio... Large,majorities also believe these types of trea...

... N.Y.--(BUSINESS WIRE)--May 1, 2007 - Progenics,Ph... positive,results from the first clinical trial of... infected with the human immunodeficiency,virus (H...ng a,single 5.0 mg/kg dose of PRO 140 achieved an ...n the blood of 98.5% (1.83,log10), with individual...

Other Medicine Technology:Eighty-one Percent of U.S. Adults say that Birth Control Pills and,Procedures Should Be Covered by Health Insurance 2 Eighty-one Percent of U.S. Adults say that Birth Control Pills and,Procedures Should Be Covered by Health Insurance 3 Eighty-one Percent of U.S. Adults say that Birth Control Pills and,Procedures Should Be Covered by Health Insurance 4 Progenics Announces Positive Results in Clinical Trial of Novel HIV,Therapy 2 Progenics Announces Positive Results in Clinical Trial of Novel HIV,Therapy 3 Progenics Announces Positive Results in Clinical Trial of Novel HIV,Therapy 4 Progenics Announces Positive Results in Clinical Trial of Novel HIV,Therapy 5 Progenics Announces Positive Results in Clinical Trial of Novel HIV,Therapy 6 Progenics Announces Positive Results in Clinical Trial of Novel HIV,Therapy 7

Eighty-one Percent of U.S. Adults say that Birth Control Pills and,Procedures Should Be Covered by Health Insurance Progenics Announces Positive Results in Clinical Trial of Novel HIV,Therapy

Onyx® II 9550

FetalSAT™

8600FO MRI

2100 Pulse Oximeter

Medicine Products:

Onyx® II 9550 FetalSAT™8600FO MRI 2100 Pulse Oximeter

Haemacure to Present at the BioFinance 2008 Conference to be held at the Toronto Marriott Eaton Centre, May 6...( HAE...),Health